Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2018 Jul;25(4):176-182.
doi: 10.1136/ejhpharm-2016-001107. Epub 2017 Mar 3.

A retrospective and observational analysis of harmful excipients in medicines for hospitalised neonates in Latvia

Affiliations

A retrospective and observational analysis of harmful excipients in medicines for hospitalised neonates in Latvia

Inese Sviestina et al. Eur J Hosp Pharm. 2018 Jul.

Abstract

Background: Medicines used in neonates contain different excipients, which may not be safe in this age group.

Objective: To analyse the frequency at which hospitalised neonates are exposed to harmful excipients (HEs) and to identify substitution possibilities for medicines containing HEs.

Materials and methods: Retrospective, observational study at a university paediatric hospital from 1 September 2015 till 29 February 2016. All hospitalised neonates who received a prescription for medicines containing an HE were included. Neonates were divided into four groups according to gestational age (<28 weeks; 28 to <32 weeks; 32 to <37 weeks and ≥37 weeks). The following excipients were analysed: parabens, polysorbate 80, propylene glycol, benzoates, saccharin sodium, sorbitol, ethanol and benzalkonium chloride. Excipients were identified from the Summaries of Product Characteristics.

Results: 296 (102(34.5%) preterm) neonates included in the study received 1472 prescriptions for 106 medicines. The most often used formulations were intravenous (48/106; 45.3%) and oral solid formulations (20; 18.9%). The total number of different excipients was 169. In total, 29/106 (27.4%) medicines contained at least one HE. In total 82/102 (80.4%) preterm and 118/194 (60.8%) term neonates received medications with at least one HE. Substitution was possible for 9/29 (31.0%) HE-containing medicines.

Conclusions: Use of HEs can be reduced by using HE-free products available on the European market. However, medicine substitution was possible in only a small number of cases. Therefore the main focus should be on information and education of the hospital specialists about HEs used in medicines and their adverse reactions.

Keywords: harmful excipients; hospitals; neonates; pharmaceutical excipients; substitution of harmful excipients.

PubMed Disclaimer

Conflict of interest statement

Competing interests: None declared.

Figures

Figure 1
Figure 1
Number of medicines with and without HE excipients Figure 1 87x50mm (600 x 600 DPI).

References

    1. Marek E, Kraft WK. Ethanol pharmacokinetics in neonates and infants. Curr Ther Res Clin Exp 2014;76:90–7. 10.1016/j.curtheres.2014.09.002 - DOI - PMC - PubMed
    1. Whittaker A, Currie AE, Turner MA, et al. . Toxic additives in medication for preterm infants. Arch Dis Child Fetal Neonatal Ed 2009;94:F236–40. 10.1136/adc.2008.146035 - DOI - PubMed
    1. Alade SL, Brown RE, Paquet A Jr. Polysorbate 80 and E-Ferol toxicity. Pediatrics 1986;77:593–7. - PubMed
    1. Masi S, de Cléty SC, Anslot C, et al. . Acute amiodarone toxicity due to an administration error: could excipient be responsible? Br J Clin Pharmacol 2009;67:691–3. 10.1111/j.1365-2125.2008.03323.x - DOI - PMC - PubMed
    1. Fabiano V, Mameli C, Zuccotti GV. Paediatric pharmacology: Remember the excipients. Pharmacol Res 2011;63:362–5. 10.1016/j.phrs.2011.01.006 - DOI - PubMed